Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer’s disease

This publication has 21 references indexed in Scilit:

• Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
  Neurology, 2004
• Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ42 levels in Alzheimer’s disease
  Human Genetics, 2004
• Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease
  Molecular Psychiatry, 2002
• β-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease
  Archives of Neurology, 2002
• Regulation of Cholesterol Homeostasis by the Liver X Receptors in the Central Nervous System
  Molecular Endocrinology, 2002
• A Cholesterol-Lowering Drug Reduces β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
  Neurobiology of Disease, 2001
• Primary cultures of neuronal and non-neuronal rat brain cells secrete similar proportions of amyloid β peptides ending at Aβ40 and Aβ42
  NeuroReport, 1999
• Cholesterol depletion inhibits the generation of β-amyloid in hippocampal neurons
  Proceedings of the National Academy of Sciences, 1998
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
  Neurology, 1991
• Clinical diagnosis of Alzheimer's disease
  Neurology, 1984